Skip to content

Visual performance of a new intra ocular lens

Evaluation of the visual performance of Clareon intraocular lens after bilateral implantation in patients targeted for mini-monovision - A prospective, single center, longitudinal study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043199
Enrollment
45
Registered
2022-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H251- Age-related nuclear cataract

Interventions

None listed

Sponsors

Alcon Laboratories India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have been implanted bilaterally with Clareon intraocular lens (IOL; model SY60CL; Alcon Vision LLC) Uncomplicated age related cataract who underwent uncomplicated bilateral cataract surgery by phacoemulsification technique Preoperative & postoperative corneal astigmatism of = 0.75 D Willing to provide consent for follow-up Completed all the study follow-up as per the protocol

Exclusion criteria

Exclusion criteria: Subjects with prior history of any intraocular surgery Subject who underwent any additional procedures during cataract surgery Subjects who underwent complicated cataract surgery Subjects who had any post-operative complications Any active ocular disease (Diabetic retinopathy, macular degeneration, glaucoma with field defects and irregular corneal astigmatism) Post op manifest refraction(Spherical Equivalent) > +/-0.25 D in the dominant eye and -0.75 D in the non-dominant eye Subject who is not willing to sign Informed Consent Form for the study

Design outcomes

Primary

MeasureTime frame
Visual Acuity: Snellen’s visual acuity charts will be used for distance and Notation (N) charts were used for intermediate (66 centimetres) and near (40 centimetres) visual acuity.Timepoint: Screening Day 1 assessment Day 15 assessment Day 30 assessment Day 90 Assessment

Secondary

MeasureTime frame
Contrast sensitivity High Order aberrations Defocus Curve Reading Parameters Stereopsis Quality of life Photic phenomena Fundus visualizationTimepoint: Screening Day 1 assessment Day 15 assessment Day 30 assessment Day 90 Assessment

Countries

India

Contacts

Public ContactDr Suhas Haldipurkar

Laxmi Eye Institute and Laxmi Charitable Trust

info@laxmieye.org02227452228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026